欧洲 · 综合新闻 · Swissinfo
Roche Drug Outshines Amgen, Bristol Rivals in Lung Cancer Study
A Roche Holding AG drug billed as a potential blockbuster helped patients with a form of lung cancer that had spread live almost six months longer than two competitive medicines.
在 Swissinfo 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.swissinfo.ch)




/2026/10/25/6ade491b6c8b0154960027.jpg)